Diabetes and Cardiovascular Disease: Etiology, Treatment, and Outcomes: Advances in Experimental Medicine and Biology, cartea 498
Editat de Aubie Angel, Naranjan S. Dhalla, Grant N. Pierce, Pawan K. Singalen Limba Engleză Hardback – 30 noi 2001
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1107.41 lei 6-8 săpt. | |
Springer Us – 5 noi 2012 | 1107.41 lei 6-8 săpt. | |
Hardback (1) | 1117.31 lei 6-8 săpt. | |
Springer Us – 30 noi 2001 | 1117.31 lei 6-8 săpt. |
Din seria Advances in Experimental Medicine and Biology
- 9% Preț: 719.56 lei
- 5% Preț: 717.00 lei
- 5% Preț: 717.00 lei
- 15% Preț: 640.24 lei
- 5% Preț: 715.71 lei
- 5% Preț: 716.28 lei
- 20% Preț: 691.93 lei
- 5% Preț: 1031.00 lei
- 5% Preț: 820.42 lei
- 5% Preț: 716.28 lei
- 15% Preț: 641.38 lei
- 5% Preț: 717.20 lei
- 5% Preț: 715.35 lei
- 5% Preț: 1113.83 lei
- 20% Preț: 1161.71 lei
- 5% Preț: 1170.51 lei
- 18% Preț: 1119.87 lei
- 5% Preț: 1288.48 lei
- 5% Preț: 1164.67 lei
- 5% Preț: 1101.73 lei
- 18% Preț: 1123.67 lei
- 5% Preț: 1435.64 lei
- 20% Preț: 1044.10 lei
- 18% Preț: 946.39 lei
- 5% Preț: 292.57 lei
- 18% Preț: 957.62 lei
- 18% Preț: 1235.76 lei
- 5% Preț: 1231.55 lei
- 5% Preț: 1292.30 lei
- 5% Preț: 1102.10 lei
- 18% Preț: 1132.81 lei
- 5% Preț: 1165.19 lei
- 5% Preț: 1418.48 lei
- 5% Preț: 1305.63 lei
- 18% Preț: 1417.72 lei
- 18% Preț: 1412.99 lei
- 24% Preț: 806.15 lei
- 18% Preț: 1243.29 lei
- 5% Preț: 1429.44 lei
- 5% Preț: 1618.70 lei
- 5% Preț: 1305.12 lei
- 18% Preț: 1124.92 lei
- 5% Preț: 1097.54 lei
- 15% Preț: 649.87 lei
- 5% Preț: 1097.54 lei
- 18% Preț: 945.79 lei
- 5% Preț: 1123.13 lei
- 20% Preț: 816.43 lei
Preț: 1117.31 lei
Preț vechi: 1176.11 lei
-5% Nou
Puncte Express: 1676
Preț estimativ în valută:
213.82€ • 222.95$ • 177.71£
213.82€ • 222.95$ • 177.71£
Carte tipărită la comandă
Livrare economică 21 martie-04 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780306466373
ISBN-10: 0306466376
Pagini: 415
Ilustrații: XI, 415 p.
Dimensiuni: 178 x 254 x 36 mm
Greutate: 0.99 kg
Ediția:2001
Editura: Springer Us
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
ISBN-10: 0306466376
Pagini: 415
Ilustrații: XI, 415 p.
Dimensiuni: 178 x 254 x 36 mm
Greutate: 0.99 kg
Ediția:2001
Editura: Springer Us
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Epidemiology and Genetic Determinants of Diabetes Mellitus.- 1. Type 2 Diabetes in Youth: A New Epidemic.- 2. Undiagnosed Diabetes: Burden and Significance in the Canadian Population.- 3. Genes, Environment and Diabetes in Canadian Aboriginal Communities.- 4. Diabetes in Sub-Saharan Africa.- 5. Coronary Heart Disease and Risk Factors in Asian Indians.- Metabolic Risk Factors in Diabetes and Cardiovascular Disease.- 6. The Plasma Glucose Level—A Continuous Risk Factor for Vascular Disease in Both Diabetic and Non-Diabetic People.- 7. Modified Lipoproteins and Cardiovascular Risk.- 8. Advances in Lipid-Lowering Therapy in Atherosclerosis.- 9. Homocysteine as a Risk Factor in Cardiovascular Disease.- 10. Endothelial Integrity and Repair.- 11. Molecular Mechanisms of Endothelial Dysfunction in the Diabetic Heart….- 12. A Study of Vascular Wound Healing in a Rabbit Model of Type I Diabetes.- 13. Endothelins in the Microvasculature and Heart in Diabetes.- 14. Diabetes and Endothelial Function: Implications for Coronary Angioplasty.- Hypertension and Diabetes Mellitus.- 15. The Effect of Hypertension in Diabetes.- 16. The Diabetic Hypertensive (or Hypertensive Diabetic)—A Compelling Need to Optimize Blood Pressure.- 17. Left Ventricular Diastolic Dysfunction in Diabetic or Hypertensive Subjects: Role of Collagen Alterations.- 18. Alterations in the Vascular Actions of Insulin in the Pathogenesis of Insulin Resistance and Hypertension.- 19. Cardiac Hypertrophy in Diabetes Patients with and without Hypertension: Effects of Troglitazone, a Novel Antidiabetic Drug, on Diastolic Function.- 20. Cost and Benefits of Blood Pressure Monitoring and Control.- Cardiac Lipid Metabolism in Diabetes.- 21. Malonyl COA Control of Fatty Acid Oxidation in the Diabetic Rat Heart.- 22.Alterations in 1,2-Diacylglycerol and Ceramides in Diabetic Rat Heart.- 23. Regulation of Myocardial Phospholipid N-Methylation by Insulin and Diabetes.- 24. Reduction of Phosphatidylinositol-4,5-Bisphosphate Mass in Heart Sarcolemma during Diabetic Cardiomyopathy.- 25. Tumor Necrosis Factor-?, Sphingomyelinase and Ceramides Activate Tyrosine Kinase, p21Ras and Phosphatidylinositol 3-Kinase: Implications for Glucose Transport and Insulin Resistance.- Cardiac Function and Oxidative Stress in Diabetes.- 26. Antioxidants, Free Radical Stress and Diabetes.- 27. Oxidative Stress and Functional Deficit in Diabetic Cardiomyopathy.- 28. Ketosis and the Generation of Oxygen Radicals in Diabetes Mellitus.- 29. Effect of Diabetes Mellitus on Hemodynamic and Cardiometabolic Correlates in Experimental Myocardial Infarction.- 30. Cardiac Function in Perfused Hearts from Diabetic Mice.- 31. Mg2+-Dependent Atpase Activity in Cardiac Myofibrils from the Insulin-Resistant Jcr:La-Cp Rat.- 32. Cyclic Nucleotide Phosphodiesterase Families in Intracellular Signaling and Diabetes.- 33. Alterations in G-Protein-Linked Signal Transduction in Cardiovascular Vascular Smooth Muscle in Diabetes.- Glycemic Control and Improved Cardiovascular Function.- 34. Mechanism of HDL Lowering in Insulin Resistant States.- 35. Insulin Treatment Post Myocardial Infarction: The Digami Study.- 36. Response to Ischemia and Endogenous Myocardial Protection in the Diabetic Heart.- 37. Type 2 Diabetes: Pharmacological Intervention in an Animal Model.- 38. The Diabetic Heart and Cardiac Glycosides.- 39. Hyperglycemia-Induced Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells: Implications in the Pathogenesis of Vascular Dysfunction in Diabetes.- 40. Regulation of Myocardial and Skeletal MuscleNA,K-ATPase in Diabetes Mellitus in Humans and Animals.- Diabetes Management— A Multidisciplinary Approach.- 41. Food Strategies for Diabetes and Heart Health.- 42. The Atherosclerosis Reversal Clinic: The Way of the Future.- 43. Lipid Clinics/Cardiovascular Risk Reduction Clinics: Current State and Future Consideration.- 44. Amputation Prevention and Rehabilitation in Diabetes.- 45. Laboratory Testing in Diabetes Mellitus.- Health Promotion in Preventing Diabetes and Its Complications.- 46. Diabetes and Cardiovascular Disease.- 47. Prevalence of Cardiovascular Risk Factors in Canadians with Diabetes Mellitus.- 48. G7 Project Promoting Heart Health.- 49. Canadian Heart Health Initiative: Research Review.- Health Policy and National Strategies in Diabetes.- 50. Putting Policy into Action.- 51. National and International Strategies to Prevent Obesity and Diabetes.- 52. The Diabetes Council of Canada (DCC): Coordinating National Diabetes Strategies.- 53. The Federal Government and Diabetes: An Incremental Process.